Thus, the MGPs developed both with ER+ and ER– breast cancer cells were not predictive for ER– patients, which is consistent with previous studies that reported difficulties in prediction of pCR in ER– cancers [36], [37], [38], [39]. The gene discussed is ESR1; the disease is breast cancer.